Patent · US Expired

Identification of surface-associated antigens for tumor diagnosis and therapy

US7785801B2 · kind B2 · utility

11Cited by

1References

4Claims

0Family size

Assignee

Ganymed Pharmaceuticals GmbH · DE

Inventors

Ozlem Tureci · Homburg, DE
Ugur Sahin · Mainz, DE
Sandra Schneider · Blankenloch, DE
Gerd Helftenbein · Mücke, DE
Volker Schlüter · Schwanau, DE
Dirk Usener · Wiesbaden, DE
Philippe Thiel · Planegg, DE
Michael Koslowski · Mainz, DE

Key dates

Filing date	May 11, 2005
Grant date	Aug 31, 2010
Priority date	—
Expiry date	Dec 11, 2025

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/53
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the identification of gene products that are the result of tumor-associated expression and the nucleic acids encoding the same. The invention also relates to the therapy and diagnosis of diseases wherein these gene products are the result of an aberrant tumor-associated expression. The invention also relates to the proteins, polypeptides and peptides that are the result of tumor-associated expression and to the nucleic acids encoding the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.